<p>根據其最近向美國證券交易委員會（SEC）披露的信息，Baillie Gifford &amp; Co.在第三季度購買了 Heartflow, Inc.（NASDAQ:HTFL - 免費報告）的新頭寸。該公司購買了 3,005,998 股該公司的股票，價值約為 101,182,000 美元。截至其最近向 SEC 提交的文件，Baillie Gifford &amp; Co.持有 Heartflow 3.60% 的股份。</p>
<p>其他幾家對沖基金也買賣了 HTFL 的股票。Emerald Mutual Fund Advisers Trust 在第三季度購買了價值約 4,418,000 美元的 Heartflow 新頭寸。TrueMark Investments LLC 在第三季度購買了價值約 918,000 美元的 Heartflow 新頭寸。最後，TFC Financial Management Inc.在第三季度購買了價值約 40,000 美元的 Heartflow 新股份。</p>
<h2>華爾街分析師觀點</h2>
<p>一些股票分析師對該股票發表了看法。Stifel Nicolaus 將 Heartflow 的目標股價從 35.00 美元上調至 40.00 美元，並在 11 月 13 日的研究報告中給予該股票 “買入” 評級。Canaccord Genuity Group 將 Heartflow 的目標股價從 39.00 美元上調至 40.00 美元，並在 11 月 13 日的研究報告中給予該公司 “買入” 評級。Weiss Ratings 在 12 月 29 日的研究報告中重申了對 Heartflow 的 “賣出（d）” 評級。最後，摩根大通將 Heartflow 的目標股價從 36.00 美元上調至 40.00 美元，並在 11 月 13 日的報告中給予該公司 “增持” 評級。四位投資分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 “持有”，共識目標價為 38.60 美元。</p>
<p><strong>查看我們關於 HTFL 的最新研究報告</strong></p>
<h2>Heartflow 股價下跌 4.0%</h2>
<p>NASDAQ:HTFL 的股票在週五以 32.16 美元開盤。該公司的市值為 27.4 億美元，市盈率為-17.77。該股票的 50 日移動平均線為 30.42 美元。Heartflow, Inc.的 52 周低點為 25.38 美元，52 周高點為 41.22 美元。</p>
<h2>Heartflow 內部活動</h2>
<p>在其他新聞中，董事 Jeffrey C. Lightcap 於 12 月 16 日以每股 26.34 美元的平均價格購買了 40,000 股該公司的股票，總交易額為 1,053,600.00 美元。交易完成後，該董事直接持有該公司 40,000 股，價值約為 1,053,600 美元。這筆交易代表了其持股的∞增長。該收購在向證券交易委員會的文件中披露，相關信息可通過 SEC 網站獲取。</p>
<h2>Heartflow 公司簡介</h2>
<p>（免費報告）</p>
<p>HeartFlow, Inc. NASDAQ: HTFL 是一家醫療技術公司，開發用於冠狀動脈疾病的非侵入性診斷解決方案。該公司的核心產品將冠狀動脈 CT 血管造影（CTA）數據轉化為患者特定的三維生理模型。通過先進的圖像處理和計算建模，HeartFlow 的分析估算冠狀動脈樹中的分數流量儲備（FFR）值，以識別導致缺血的病變，而無需進行侵入性的壓力導絲測量。</p>
<p>HeartFlow 的基於雲的服務與臨牀工作流程集成：臨牀醫生提交冠狀動脈 CTA 圖像，並收到詳細的彩色三維地圖和報告，突出顯示特定病變的 FFR 值和生理影響。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票比 Heartflow 更好</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>沒有人告訴你的 100 萬億 AI 故事</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>用這四個簡單步驟 “防止” 您的銀行賬户受到影響</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFRGTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFRGTA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在 Heartflow 嗎？</h2>
<p>在您考慮 Heartflow 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 Heartflow 並不在名單上。</p>
<p>雖然 Heartflow 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HTFL

<p>Baillie Gifford & Co. 在 Heartflow, Inc. (NASDAQ:HTFL) 中獲得了一個新頭寸，在第三季度購買了 3,005,998 股，價值約為 1.0118 億美元。這項投資代表了該公司 3.60% 的股權。其他對沖基金也投資了 Heartflow。分析師對該股票的評級不一，普遍目標價為 38.60 美元。Heartflow 的股票開盤價為 32.16 美元，市值為 27.4 億美元。該公司專注於冠狀動脈疾病的非侵入性診斷解決方案</p>

<p>Baillie Gifford &amp; Co. bought a new position in Heartflow, Inc. (NASDAQ:HTFL - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 3,005,998 shares of the company's stock, valued at approximately $101,182,000. Baillie Gifford &amp; Co. owned 3.60% of Heartflow as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>根據其最近向美國證券交易委員會（SEC）披露的信息，Baillie Gifford &amp; Co.在第三季度購買了 Heartflow, Inc.（NASDAQ:HTFL - 免費報告）的新頭寸。該公司購買了 3,005,998 股該公司的股票，價值約為 101,182,000 美元。截至其最近向 SEC 提交的文件，Baillie Gifford &amp; Co.持有 Heartflow 3.60% 的股份。</p>
</div><p>Several other hedge funds have also bought and sold shares of HTFL. Emerald Mutual Fund Advisers Trust bought a new position in shares of Heartflow in the third quarter worth about $4,418,000. TrueMark Investments LLC bought a new position in shares of Heartflow during the 3rd quarter valued at approximately $918,000. Finally, TFC Financial Management Inc. purchased a new stake in Heartflow in the 3rd quarter worth approximately $40,000.</p>
<div class="lb-trans"><p>其他幾家對沖基金也買賣了 HTFL 的股票。Emerald Mutual Fund Advisers Trust 在第三季度購買了價值約 4,418,000 美元的 Heartflow 新頭寸。TrueMark Investments LLC 在第三季度購買了價值約 918,000 美元的 Heartflow 新頭寸。最後，TFC Financial Management Inc.在第三季度購買了價值約 40,000 美元的 Heartflow 新股份。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>A number of equities analysts have weighed in on the stock. Stifel Nicolaus upped their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, November 13th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $39.00 to $40.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, November 13th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Heartflow in a research note on Monday, December 29th. Finally, JPMorgan Chase &amp; Co. raised their price target on Heartflow from $36.00 to $40.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, November 13th. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of &#34;Hold&#34; and a consensus price target of $38.60.</p>
<div class="lb-trans"><p>一些股票分析師對該股票發表了看法。Stifel Nicolaus 將 Heartflow 的目標股價從 35.00 美元上調至 40.00 美元，並在 11 月 13 日的研究報告中給予該股票 “買入” 評級。Canaccord Genuity Group 將 Heartflow 的目標股價從 39.00 美元上調至 40.00 美元，並在 11 月 13 日的研究報告中給予該公司 “買入” 評級。Weiss Ratings 在 12 月 29 日的研究報告中重申了對 Heartflow 的 “賣出（d）” 評級。最後，摩根大通將 Heartflow 的目標股價從 36.00 美元上調至 40.00 美元，並在 11 月 13 日的報告中給予該公司 “增持” 評級。四位投資分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 “持有”，共識目標價為 38.60 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on HTFL</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 HTFL 的最新研究報告</strong></p>
</div><h2>Heartflow Trading Down 4.0%</h2>
<div class="lb-trans"><h2>Heartflow 股價下跌 4.0%</h2>
</div><p>Shares of NASDAQ:HTFL opened at $32.16 on Friday. The company has a market capitalization of $2.74 billion and a price-to-earnings ratio of -17.77. The stock's fifty day moving average is $30.42. Heartflow, Inc. has a fifty-two week low of $25.38 and a fifty-two week high of $41.22.</p>
<div class="lb-trans"><p>NASDAQ:HTFL 的股票在週五以 32.16 美元開盤。該公司的市值為 27.4 億美元，市盈率為-17.77。該股票的 50 日移動平均線為 30.42 美元。Heartflow, Inc.的 52 周低點為 25.38 美元，52 周高點為 41.22 美元。</p>
</div><h2>Insider Activity at Heartflow</h2>
<div class="lb-trans"><h2>Heartflow 內部活動</h2>
</div><p>In other news, Director Jeffrey C. Lightcap acquired 40,000 shares of the business's stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the transaction, the director directly owned 40,000 shares in the company, valued at approximately $1,053,600. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through the SEC website.</p>
<div class="lb-trans"><p>在其他新聞中，董事 Jeffrey C. Lightcap 於 12 月 16 日以每股 26.34 美元的平均價格購買了 40,000 股該公司的股票，總交易額為 1,053,600.00 美元。交易完成後，該董事直接持有該公司 40,000 股，價值約為 1,053,600 美元。這筆交易代表了其持股的∞增長。該收購在向證券交易委員會的文件中披露，相關信息可通過 SEC 網站獲取。</p>
</div><h2>Heartflow Company Profile</h2>
<div class="lb-trans"><h2>Heartflow 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.</p>
<div class="lb-trans"><p>HeartFlow, Inc. NASDAQ: HTFL 是一家醫療技術公司，開發用於冠狀動脈疾病的非侵入性診斷解決方案。該公司的核心產品將冠狀動脈 CT 血管造影（CTA）數據轉化為患者特定的三維生理模型。通過先進的圖像處理和計算建模，HeartFlow 的分析估算冠狀動脈樹中的分數流量儲備（FFR）值，以識別導致缺血的病變，而無需進行侵入性的壓力導絲測量。</p>
</div><p>HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.</p>
<div class="lb-trans"><p>HeartFlow 的基於雲的服務與臨牀工作流程集成：臨牀醫生提交冠狀動脈 CTA 圖像，並收到詳細的彩色三維地圖和報告，突出顯示特定病變的 FFR 值和生理影響。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Heartflow</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>The $100 Trillion AI Story No One Is Telling You</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比 Heartflow 更好</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>沒有人告訴你的 100 萬億 AI 故事</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>用這四個簡單步驟 “防止” 您的銀行賬户受到影響</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFRGTA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=HTFL"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Heartflow Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在 Heartflow 嗎？</h2>
</div><p>Before you consider Heartflow, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Heartflow 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 Heartflow 並不在名單上。</p>
</div><p>While Heartflow currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Heartflow 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Baillie Gifford & Co. 在 HeartFlow, Inc. $HTFL 中建立了價值 1.0118 億美元的頭寸